Pitcairn Co. reduced its stake in Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX – Get Rating ) by 6.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 4,253 shares of the pharmaceutical company's stock after selling 275 shares during the quarter. Pitcairn Co.'s holdings in Vertex Pharmaceuticals were worth $1,228,000 at the end of the most recent reporting period. Other institutional investors have also made changes to their positions in the company. Sequoia Financial Advisors LLC raised its position in Vertex Pharmaceuticals by 145.

https://www.dailypolitical.com/2023/05/30/pitcairn-co-sells-275-shares-of-vertex-pharmaceuticals-incorporated-nasdaqvrtx.html

#dailypolitical